ENTPD1 and chronic kidney disease: Therefore, this study aimed to measure the activity of purinergic enzymes, such as NTPDase (CD39) and ecto-5′-nucleotidase (CD73) as well as adenosine deaminase (ADA) in platelets of patients with CKD that performed a resistance physical protocol of 12 weeks undergoing hemodialysis.